NTK Panel
NTK assays are currently offered for cerebrospinal fluid (CSF) and/or blood
![](https://assets.alzheimersdata.org/7373eebf-cfbb-00c0-d001-2efabc5eba75/7917a2b4-91f3-4af6-b27f-1f2751b97c22/NTK-Biomarker-Chart-3NEW.png?auto=format)
The NTK portfolio is measured in four measurement sites
![](https://assets.alzheimersdata.org/7373eebf-cfbb-00c0-d001-2efabc5eba75/f5eb770f-e5ff-4862-bd38-16f9ffd25e79/NTK-Biomarker-Map-2.png?auto=format)
The power of Elecsys® in Alzheimer's disease
Robust and accurate biomarker tests to solve clinical questions
- Elecsys® assays achieve highly accurate and precise results across all Cobas® platforms, with the precision being confirmed in the Alzheimer's Association Quality Control (AAQC) program;
- Elecsys® assays show robust reagent and calibration stability.
To learn more about the Power of Elecsys, please click here.